Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05814458 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Efficiency of Transcranial Direct Current Stimulation in the Treatment of Anorexia Nervosa

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 2, 2026 (before its estimated September 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Dec 30, 2025 to Sep 30, 2026
    • Primary endpoints: 16 to 22
    • Secondary endpoints: 19 to 26
    v4
  2. Primary and study completion dates: Dec 30, 2024 to Dec 30, 2025v3 Show 4 more changesShow less
    • Primary endpoints: 15 to 16
    • Trial status: Recruiting to Active, Not Recruiting
    • Eligibility criteria revised
    • Site details revised
  3. Secondary endpoints: 20 to 19v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The main goal of the study (a 3-week, randomized, double-blind, and placebo-controlled study) is to determine the effect of Transcranial Direct Current Stimulation (tDCS) on the mental state and advances in nutritional rehabilitation in patients with AN. The primary hypothesis assumes that tDCS will reduce the symptoms of depression, improve cognition functions and it will have a positive effect on the reduction of restriction related to body weight and diet.
Trial Details
NCT Number NCT05814458
Lead Sponsor Medical University of Lublin
Conditions
(from sponsor)		 Anorexia Nervosa
Related terms Anorexia Nervosa, Feeding and Eating Disorders
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov